Cancers were typed for estrogen receptors (ER), progesterone receptors (PR), and HER2, and included nine cases with germline mutations in the breast cancer predisposition genes BRCA1 (five) and BRCA2 (four) (Table S1A, available online). The gene discussed is BRCA2; the disease is cancer.